Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
30 studies found for:    " August 19, 2012":" September 18, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 19, 2012":" September 18, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients
Conditions: HIV;   Acquired Immunodeficiency Syndrome;   Alcoholism;   Alcoholic Intoxication;   Substance-Related Disorders
Interventions: Behavioral: Motivational Interviewing;   Behavioral: Email Feedback;   Other: Usual Care
2 Completed Efficacy of HIV Post-Test Support for ANC in South Africa
Conditions: HIV;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Enhanced Counseling;   Behavioral: Standard of Care
3 Recruiting Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: antiretroviral therapy;   Behavioral: cell phone reminders;   Behavioral: contingency management for adherence
4 Unknown  Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients
Condition: HIV Infection
Intervention: Procedure: colonoscopy with endoscopic biopsies
5 Completed Body Image in Youth With HIV
Conditions: Human Immunodeficiency Virus;   HIV
Intervention: Other: Questionnaire
6 Recruiting Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)
Conditions: Human Immunodeficiency Virus;   Immune Reconstitution Inflammatory Syndrome
Interventions: Other: Urgent ART;   Other: Early ART
7 Completed A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Conditions: Liver Fibrosis;   Hepatitis C;   HIV;   HIV/HCV Co-infection
Intervention: Biological: Simtuzumab
8 Recruiting Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
Conditions: Solid Organ Transplant Recipient (Liver, Kidney, Heart);   Rheumatologic Disorder;   Human Immunodeficiency Virus (HIV);   Bone Marrow Transplant (BMT);   Dialysis
Interventions: Biological: Fluzone High Dose;   Biological: Fluzone
9 Active, not recruiting Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Conditions: Cardiovascular Diseases;   HIV
Intervention:
10 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
11 Unknown  HIV Indicator Diseases Across Europe Study
Condition: HIV
Intervention:
12 Completed Increasing Availability and Acceptability of Circumcision in Zambia
Condition: HIV
Intervention: Behavioral: MC and sexual risk reduction
13 Completed Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU
Condition: HIV
Interventions: Behavioral: Individual level;   Behavioral: Structural level;   Behavioral: Individual level standard of care;   Behavioral: Structural level standard of care
14 Recruiting Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana
Conditions: Tuberculosis;   HIV
Intervention:
15 Recruiting Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations
Condition: HIV Infection
Intervention: Behavioral: Integrated care centers
16 Terminated Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Conditions: HIV Infection;   Malaria
Intervention: Drug: Artemether/Lumefantrine (AL)
17 Completed Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
Condition: HIV
Interventions: Drug: Tenofovir;   Drug: Zidovudine
18 Unknown  Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Conditions: HIV Infection;   Adverse Drug Reaction;   Quality of Life
Intervention: Drug: Raltegravir switch
19 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
20 Completed Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique
Conditions: Anemia;   Fever;   HIV Positive
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years